152 related articles for article (PubMed ID: 24662034)
1. Integrative clinical transcriptomics analyses for new therapeutic intervention strategies: a psoriasis case study.
Qu XA; Freudenberg JM; Sanseau P; Rajpal DK
Drug Discov Today; 2014 Sep; 19(9):1364-71. PubMed ID: 24662034
[TBL] [Abstract][Full Text] [Related]
2. Insight into the biomarkers as the novel anti-psoriatic drug discovery tool: a contemporary viewpoint.
Rahman M; Zaki Ahmad M; Kazmi I; Akhter S; Beg S; Gupta G; Afzal M; Saleem S; Ahmad I; Adil Shaharyar M; Jalees Ahmed F; Anwar F
Curr Drug Discov Technol; 2012 Mar; 9(1):48-62. PubMed ID: 22023258
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis drug discovery: methods for evaluation of potential drug candidates.
Svensson L; Røpke MA; Norsgaard H
Expert Opin Drug Discov; 2012 Jan; 7(1):49-61. PubMed ID: 22468893
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of tazarotene action in psoriasis.
Duvic M; Nagpal S; Asano AT; Chandraratna RA
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S18-24. PubMed ID: 9270552
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics in the pathogenesis and pathophysiology of psoriasis vulgaris.
Trowbridge RM; Pittelkow MR
J Drugs Dermatol; 2014 Feb; 13(2):111-8. PubMed ID: 24509958
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis: targeting therapy towards the inflammatory cascade.
Miteva M
Am J Clin Dermatol; 2010; 11 Suppl 1():11-3. PubMed ID: 20586499
[TBL] [Abstract][Full Text] [Related]
7. New therapies under development for psoriasis treatment.
García-Pérez ME; Stevanovic T; Poubelle PE
Curr Opin Pediatr; 2013 Aug; 25(4):480-7. PubMed ID: 23838833
[TBL] [Abstract][Full Text] [Related]
8. Translating clinical activity and gene expression signatures of etanercept and ciclosporin to the psoriasis xenograft SCID mouse model.
Norsgaard H; Svensson L; Hagedorn PH; Moller K; Olsen GM; Labuda T
Br J Dermatol; 2012 Mar; 166(3):649-52. PubMed ID: 22050597
[TBL] [Abstract][Full Text] [Related]
9. [The biological treatments for moderate to severe plaque psoriasis].
Thielen AM; Marazza G
Rev Med Suisse; 2008 Apr; 4(155):1089-90, 1092-4. PubMed ID: 18610721
[TBL] [Abstract][Full Text] [Related]
10. Anti-cytokine therapy in the treatment of psoriasis.
Kupetsky EA; Mathers AR; Ferris LK
Cytokine; 2013 Mar; 61(3):704-12. PubMed ID: 23410503
[TBL] [Abstract][Full Text] [Related]
11. Phosphoinositide-3 kinase/protein kinase-B/mammalian target of rapamycin pathway in psoriasis pathogenesis. A potential therapeutic target?
Huang T; Lin X; Meng X; Lin M
Acta Derm Venereol; 2014 Jul; 94(4):371-9. PubMed ID: 24217655
[TBL] [Abstract][Full Text] [Related]
12. Redefining clinical response in psoriasis: targeting the pathological basis of disease.
Ortonne JP
J Drugs Dermatol; 2004; 3(1):13-20. PubMed ID: 14964742
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis Therapy: Breakthroughs in Pharmacogenomics or in Pharmacology?
Lebwohl M
J Invest Dermatol; 2016 Dec; 136(12):2339-2340. PubMed ID: 27884289
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic applications in psoriasis: genetics, transcriptomics, and microbiomics.
Parad JE; Liao W
Semin Cutan Med Surg; 2019 Mar; 38(1):E3-E11. PubMed ID: 31051017
[TBL] [Abstract][Full Text] [Related]
15. Emerging therapeutic targets in psoriasis.
Bayliffe AI; Brigandi RA; Wilkins HJ; Levick MP
Curr Opin Pharmacol; 2004 Jun; 4(3):306-10. PubMed ID: 15140425
[TBL] [Abstract][Full Text] [Related]
16. The status of biologic therapies in the treatment of moderate to severe psoriasis.
Menter A
Cutis; 2009 Oct; 84(4 Suppl):14-24. PubMed ID: 19916298
[TBL] [Abstract][Full Text] [Related]
17. Advances in psoriasis physiopathology and treatments: Up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS).
Sala M; Elaissari A; Fessi H
J Control Release; 2016 Oct; 239():182-202. PubMed ID: 27381248
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of biologics with traditional agents in psoriasis.
Guenther LC
Skin Therapy Lett; 2011 Jun; 16(6):1-3. PubMed ID: 21833461
[TBL] [Abstract][Full Text] [Related]
19. Novel systemic drugs under investigation for the treatment of psoriasis.
Gudjonsson JE; Johnston A; Ellis CN
J Am Acad Dermatol; 2012 Jul; 67(1):139-47. PubMed ID: 22305044
[TBL] [Abstract][Full Text] [Related]
20. Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept.
Weinberg JM; Saini R
Cutis; 2003 Jan; 71(1):25-9. PubMed ID: 12553627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
